High-Dose Intravenous Methylprednisolone Therapy Associated with Osteonecrosis in Patients with Systemic Lupus Erythematosus

Abstract

Osteonecrosis is related to the use of steroids in patients with systemic lupus erythematosus (SLE); its association with the use of 'pulses' of methylprednisolone (PMP) is not clear at present. In a retrospective analysis of 190 patients with SLE we found that 19% of 36 patients treated with PMP had osteonecrosis compared with 6% of 154 patients without that treatment (P < 0.04). Risk factors associated with osteonecrosis were PMP treatment, cushingoid appearance, steroid doses ≥ 40 mg/day during the first month of treatment, a ratio of steroid dose in grams/year ≥ 12, hematuria and proteinuria. In a stepwise regression model, when cushingoid appearance was excluded, PMP became the only significant factor (P = 0.045).

We conclude that osteonecrosis can be considered a long-term complication of PMP treatment in SLE patients.

Keywords

Osteonecrosis Methylprednisolone Systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Wallace DJ , Dubois EL Clinical and laboratory manifestations of systemic lupus erythematosus . In: Wallace DJ , Dubois EL , eds. Dubois' Lupus Erythematosus. Philadelphia: Lea & Febiger, 1987:329-35.

Gladman DD , Urowitz M. Morbidity in systemic lupus erythematosus. J Rheumatol 1987; 14 (Suppl 13): 223-6.

Klippel JH , Gerber LH , Pollak L. , Decker JL Avascular necrosis in systemic lupus erythematosus: silent symmetric osteonecrosis . Am J Med 1979; 67: 83-7.

Abeles M. , Urman JD , Rothfield NF Aseptic necrosis of bone in systemic lupus erythematosus. Arch Intern Med 1978; 138: 750-4.

Dimant J. , Ginzler EM , Diamond HS et al. Computer analysis of factors influencing the appearance of aseptic necrosis in patients with SLE. J Rheumatol 1978; 5: 136-41.

Weiner ES , Abeles M. Aseptic necrosis and glucocorticosteroids in systemic lupus erythematosus: a reevaluation. J Rheumatol 1989; 16: 604-8.

Nagasawa K. , Ishii Y. , Mayumi T. et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis 1989; 48: 672-6.

Zizic TM , Marcoux C. , Hungerford DS , Dansereau JV , Stevens MB Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med 1985 ; 79: 596-604.

Kimberley RP Pulse methylprednisolone in SLE. Clin Rheum Dis 1982; 8: 261-78.

10.

Rivero S. , Massardo L. , Jacobelli S. Valor terapéutico y complicaciones del uso de pulsos de metilprednisolona en enfermedades del tejido conjuntivo. Rev Esp Reumatol 1983; 10: 127-32.

11.

Rothfield NF Systemic lupus erythematosus: clinical aspects and treatment. In: McCarty D , ed. Arthritis and Allied Conditions . Philadelphia: Lea & Febiger , 1989: 1022-48.

12.

Tan E. , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.

13.

Arlet J. , Ficat P. Diagnostic de l'osteonecrose femorocapitale primitive au state I (stade pré-radiologique) . Rev Chir Orthop 1968; 54: 637-48.

14.

Peto R. , Pike MC , Armitage P. et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Part I. Introduction and design. Br J Cancer 1976; 34: 585-612.

15.

Peto R. , Pike MC , Armitage P. et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Part II. Analysis and examples. Br J Cancer 1977; 35:1-39.

16.

Mathews DE , Farewell WT Binary logistic regression. In: Karger S , ed. Using and Understanding Medical Statistics. Basel: S Karger, 1985 :139-46.

17.

Zizic TM

Avascular necrosis of bone. Curr Opinion

Rheumatol 1990; 2: 26-37.

18.

Dubois EL , Cozen L. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus . JAMA 1960; 174: 966-71.

19.

Hurley RM , Steinberg RH , Patriquim H. , Drummond KN Avascular necrosis of the femoral head in childhood systemic lupus erythematosus . Can Med Assoc J 1974; 111: 781-4.

20.

Felson DT , Anderson JJ Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet 1987 ; i: 902-6.

21.

Williams IA , Mitchell AD , Rothman W. , Tallet P. , Williams K. , Pitt P. Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone. Ann Rheum Dis 1988; 47: 930-3.

22.

Shipley ME , Bacon PA , Berry H. et al. Pulse methylprednisolone in active early rheumatoid disease: a dose-ranging study. Br J Rheumatol 1988; 27: 211-4.

23.

Braun EW Nephrology forum. Long term complications of renal transplantation: avascular necrosis. Kidney Int 1990; 37: 1363-78.

24.

Jones JP Osteonecrosis. In: McCarty D , ed. Arthritis and Allied Conditions. Philadelphia : Lea & Febiger, 1989: 1545-62.

25.

Abeles M. , Weiner ES , Parke A. , Wilson D. The association of osteonecrosis in SLE with anticardiolipin antibodies . Lupus 1992; 1 (Suppl 1): 47 (abstract).

26.

Alarcón-Segovia D. , Delezé M. , Oria C. et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients. Medicine 1989 ; 68: 353-65.

27.

Ishii Y. , Nagasawa K. , Mayumi T. , Niho Y. Clinical importance of persistence of anticardiolipin antibodies in systemic lupus erythematosus. Ann Rheum Dis 1990; 49: 387-90.

28.

Asherson RA , Cervera R. The antiphospholipid syndrome: a syndrome in evolution. Ann Rheum Dis 1992 ; 51: 147-50.